CN102206680B - 基于短链核酸片段的基因电转染缓冲液及其制备和应用方法 - Google Patents
基于短链核酸片段的基因电转染缓冲液及其制备和应用方法 Download PDFInfo
- Publication number
- CN102206680B CN102206680B CN201110094160.3A CN201110094160A CN102206680B CN 102206680 B CN102206680 B CN 102206680B CN 201110094160 A CN201110094160 A CN 201110094160A CN 102206680 B CN102206680 B CN 102206680B
- Authority
- CN
- China
- Prior art keywords
- gene
- nucleic acids
- short
- chain nucleic
- damping fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 57
- 150000007523 nucleic acids Chemical group 0.000 title claims abstract description 54
- 238000001890 transfection Methods 0.000 title claims abstract description 39
- 238000013016 damping Methods 0.000 title claims abstract description 35
- 239000012530 fluid Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 23
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 22
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 22
- 230000008569 process Effects 0.000 claims abstract description 7
- 241000972773 Aulopiformes Species 0.000 claims abstract description 5
- 235000019515 salmon Nutrition 0.000 claims abstract description 5
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 8
- 239000007788 liquid Substances 0.000 abstract description 8
- 238000013467 fragmentation Methods 0.000 abstract description 4
- 238000006062 fragmentation reaction Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000001476 gene delivery Methods 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 31
- 210000004027 cell Anatomy 0.000 description 14
- 241000700605 Viruses Species 0.000 description 11
- 108060001084 Luciferase Proteins 0.000 description 10
- 239000005089 Luciferase Substances 0.000 description 10
- 108700008625 Reporter Genes Proteins 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 230000009471 action Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 4
- 229920002643 polyglutamic acid Polymers 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 238000001415 gene therapy Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 108010020346 Polyglutamic Acid Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- 229920006318 anionic polymer Polymers 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ZEQCMXZRJAAKCJ-UHFFFAOYSA-N 2,2,2-trichloroethane-1,1-diol Chemical compound OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl ZEQCMXZRJAAKCJ-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000011238 DNA vaccination Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110094160.3A CN102206680B (zh) | 2011-04-14 | 2011-04-14 | 基于短链核酸片段的基因电转染缓冲液及其制备和应用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110094160.3A CN102206680B (zh) | 2011-04-14 | 2011-04-14 | 基于短链核酸片段的基因电转染缓冲液及其制备和应用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102206680A CN102206680A (zh) | 2011-10-05 |
CN102206680B true CN102206680B (zh) | 2015-12-16 |
Family
ID=44695740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110094160.3A Active CN102206680B (zh) | 2011-04-14 | 2011-04-14 | 基于短链核酸片段的基因电转染缓冲液及其制备和应用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102206680B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105154472B (zh) * | 2015-09-28 | 2020-01-07 | 重庆高圣生物医药有限责任公司 | 哺乳动物细胞高效电转染缓冲液及其制备方法 |
RU2020100919A (ru) * | 2017-06-20 | 2021-07-20 | Цзянсу Хэнжуй Медсин Ко., Лтд. | СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1410525A (zh) * | 2001-09-21 | 2003-04-16 | 薛乐勋 | 转乙型肝炎表面抗原(HBsAg)基因盐藻的制备方法 |
-
2011
- 2011-04-14 CN CN201110094160.3A patent/CN102206680B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1410525A (zh) * | 2001-09-21 | 2003-04-16 | 薛乐勋 | 转乙型肝炎表面抗原(HBsAg)基因盐藻的制备方法 |
Non-Patent Citations (1)
Title |
---|
J.E. Symonds et al.《Electroporation of salmon sperm with plasmid DNA:evidence of enhanced sperm/DNA association》.《Aquaculture,》.1994,(第119期),313-327,具体参见第314页第3段、第324页最后一段-325页第一段、326页第二段. * |
Also Published As
Publication number | Publication date |
---|---|
CN102206680A (zh) | 2011-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tavernier et al. | mRNA as gene therapeutic: how to control protein expression | |
CN107980004A (zh) | 用于医治疾病的外泌体的用途 | |
US20220257794A1 (en) | Circular rnas for cellular therapy | |
CN104220599A (zh) | 人工核酸分子 | |
US20200299689A1 (en) | Modified cpf1 guide rna | |
JP2023509179A (ja) | Leaper技術に基づくmps ihの治療方法及び組成物 | |
KR20120094166A (ko) | 유전자 치료 적용을 위한 초나선화된 미니서클 dna | |
CN107501405A (zh) | 一种细胞自噬抑制多肽 | |
CN112662674A (zh) | 靶向编辑VEGFA基因外显子区域的gRNA及其应用 | |
JP2021519101A (ja) | ドナーdnaを連結するための改変型核酸編集システム | |
Asakiya et al. | Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications | |
CN104745551B (zh) | 利用talen敲除人***瘤病毒e6e7癌基因的方法 | |
TW200930811A (en) | Transfection reagent and method for enhancing transfection efficiency | |
CN114875053A (zh) | 一种高效稳定环状rna的构建方法及其产品 | |
CN102206680B (zh) | 基于短链核酸片段的基因电转染缓冲液及其制备和应用方法 | |
WO2013056670A1 (zh) | 小干扰RNA及其应用和抑制plk1基因表达的方法 | |
CN107441506A (zh) | 基因输送载体及其制备与应用 | |
US20230272416A1 (en) | Method and system for delivering nucleic acid | |
WO2022167009A1 (zh) | 靶向Aqp1 mRNA的sgRNA及其载体与应用 | |
CN102061310A (zh) | 人fhl1c真核表达载体的构建及其应用 | |
WO2023031856A1 (en) | Compositions and methods for rna affinity purification | |
CN106086069B (zh) | 一种转基因复合物及其制备方法与应用 | |
Paganin-Gioanni et al. | Cyclin B1 knockdown mediated by clinically approved pulsed electric fields siRNA delivery induces tumor regression in murine melanoma | |
Douzandegan et al. | Optimization of kyse-30 esophagus cancer cell line transfection using lipofectamine 2000 | |
Hu et al. | The impact of non-electrical factors on electrical gene transfer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230809 Address after: Room 7-104, Heda Pharmaceutical Valley Center, No. 291 Fucheng Road, Xiasha Street, Qiantang District, Hangzhou City, Zhejiang Province, 310018 Patentee after: Brady (Hangzhou) Scientific Instrument Co.,Ltd. Address before: 200240 No. 800, Dongchuan Road, Shanghai, Minhang District Patentee before: SHANGHAI JIAO TONG University |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: Room 7-104, Heda Pharmaceutical Valley Center, No. 291 Fucheng Road, Xiasha Street, Qiantang District, Hangzhou City, Zhejiang Province, 310018 Patentee after: Bruidi (Hangzhou) Scientific Instrument Co.,Ltd. Country or region after: China Address before: Room 7-104, Heda Pharmaceutical Valley Center, No. 291 Fucheng Road, Xiasha Street, Qiantang District, Hangzhou City, Zhejiang Province, 310018 Patentee before: Brady (Hangzhou) Scientific Instrument Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |